Edwards Lifesciences (EW) Market Capitalization (2009 - 2026)

Edwards Lifesciences has reported Market Capitalization for 18 years, with the latest figure at $52.2 billion in Q2 2026.

• On a quarterly basis, Market Capitalization rose 13.44% year-over-year to $52.2 billion in Q2 2026; TTM through Jun 2026 was $52.2 billion, a 13.44% increase from a year earlier, with the FY2025 full-year figure at $49.5 billion, up 13.61% from the prior year.
• Market Capitalization was $52.2 billion for Q2 2026 at Edwards Lifesciences, up from $46.2 billion in the prior quarter.
• The five-year high for Market Capitalization was $73.2 billion in Q1 2022, with the low at $38.9 billion in Q3 2024.
• Average Market Capitalization over 5 years is $50.1 billion, with a median of $47.9 billion recorded in 2025.
• The largest YoY upside for Market Capitalization was 40.66% in 2022 against a maximum downside of 43.87% in 2022.
• Over 5 years, Market Capitalization stood at $45.4 billion in 2022, then rose by 0.99% to $45.8 billion in 2023, then decreased by 4.93% to $43.6 billion in 2024, then advanced by 13.61% to $49.5 billion in 2025, then increased by 5.36% to $52.2 billion in 2026.
• The last three Market Capitalization figures came in at $52.2 billion (Q2 2026), $46.2 billion (Q1 2026), and $49.5 billion (Q4 2025), per Business Quant data.